Biotechnology Instruments Market - In-Depth Insights & Analysis

Biotechnology Instruments Market Overview

The Biotechnology Instruments market estimated at USD 48.00 Billion in the year 2023, is projected to reach a revised size of USD 77.06 Billion by 2032, growing at a CAGR of 5.4% over the analysis period 2024-2032

Human civilization has been harnessing biological processes to enhance their standard of living for some 10,000 years, beginning with the first agricultural communities. Approximately 6,000 years ago, humans utilized the biological methods of microorganisms to make alcoholic beverages, bread, cheese, and to preserve dairy products. Recently, due to the advent of biotechnology instruments, all these processes have become effortless and new technologies have been discovered to increase the yield.

Biotechnology is any technological application that incorporates the usage of biological systems, living organisms, or derivatives thereof, to manufacture or to upgrade products or processes for specific use. Furthermore, the field of biotechnology instruments has observed a tremendous rise since the start of the Human Genome Project in 1990. Although the biotechnology instrument industry existed before the start of the project, it was the Human Genome Project with its major access to key universities, national laboratories, and government funding sources that gave great acceleration to the field thus, stimulating the growth of the Biotechnology Instruments Market in the late 20th century. Moreover, the tremendous growth in technology has increased the complexity of instruments. These modern-day sophisticated biotechnology instruments are utilized for the production of vaccines, developing novel therapies and diagnostics tests, gene modifications, and are almost employed in every life science-related field thus, promoting the extension of biotechnology instruments throughout the forecast. The usage of biotechnology in the agriculture sector led to the rise of transgenic crops that have high yields and resistant qualities to pests and diseases. Moreover, Biotechnology instruments can also be employed to degrade toxic or harmful chemicals and agents to solve environmental problems thus, promoting the growth of the biotechnology instruments in the period of forecast.

COVID-19 Impact on Biotechnology Instruments Market

The outbreak of COVID-19 has severely affected the functioning of several industries. To prevent the transmission of COVID-19 disease several governments declared shutdown of the country. Moreover, the consequences of the shutdown resulted in disruptions of the supply chain, import and exports of commodities, and a sharp decline in the production of several goods. The COVID-19 pandemic has increased the demand for PCR tests as there are only tests available to detect the presence of the SARS CoV-2 virus. Moreover, the demand for medicines to treat symptoms and vaccines to boost immunity, significantly increased in the pandemic era thus, to manufacture these essential commodities on large scale, biotechnology instruments were incorporated. Furthermore, various methods were administered to decipher the genetic code and to develop medicines and vaccines effective against the virus. As a result of the pandemic, administrations have shifted their focus to infectious disease research and to discover novel therapies and diagnostics tests for new clinical groups depending on age and sex. Furthermore, pandemics made researchers realize immunology is central to all and to apply to all diseases. There is hope for even more ground-breaking solutions in the future if companies are innovative and eager to rethink their research thus COVID-19 pandemic has boosted the development of the biotechnology instruments market.

Market Dynamics And Key Factors In Biotechnology Instruments Market

Drivers:

With the rise in technological advancements and the increasing knowledge in the biotechnology sector, the demand for biotechnology instruments has significantly grown. Moreover, in healthcare and pharmaceutical applications, biotechnology has boosted the development and discovery of advanced medicines, therapies, diagnostics, and vaccines. Furthermore, breakthroughs in biotechnological techniques have generated new medicines for patients suffering from growth diseases, metabolic diseases, multiple sclerosis (MS), rheumatoid arthritis, cancer, and Alzheimer's disease thus driving the expansion of the Biotechnology Instruments Market during the forecast period.

In other sectors such as agriculture, livestock, veterinary, and aquaculture, biotechnology has enhanced animal feed, produced broad-spectrum vaccines for livestock, and improved diagnostic techniques for detecting diseases such as Bovine spongiform encephalopathy (BSE), foot and mouth disease, and salmonella with the help of advance biotechnology instruments. Furthermore, biotechnology instruments have also enabled the efficient usage of enzymes for food processing and improved the breeding of plants to obtain required characteristics thus, stimulating the growth of the Biotechnology Instruments Market in the forecast period.

In industrial processes and manufacturing, with the advent of biotechnology instruments, the incorporation of enzymes in the production of detergents, pulp and paper, textiles, and biomass has been achieved. Moreover, by utilizing fermentation and enzyme biocatalysis instead of traditional chemical synthesis, higher process efficiency and reduction in energy and water consumption can be obtained. This process leads to less release of toxic waste thus, encouraging the expansion of the Biotechnology Instruments Market throughout the forecast.

Restraints:

The growing concern about genetically modified crops and the adverse side effects on human health is hampering the usage of biotechnology instruments in the agricultural sector. Furthermore, the minute chances of leakage of certain harmful viruses and bacteria from research institutions is still a matter of concern questioning the effectiveness of biotechnology instruments. The popularity of biotechnology instruments has created some counterfeit instruments that can create a hazard while handling some harmful microorganisms thus hindering the expansion of the biotechnology instruments market. Moreover, as biotechnology instruments are utilized for the production of vaccines, the same instruments can be employed for the production of harmful viruses that can have a huge negative impact on human health and can create a huge economic crisis. The usage of biotechnology instruments in the agricultural sector can spread crop diseases contaminating the natural gene pool of specific crop species thus, restricting the growth of the Biotechnology Instruments Market in the forecast period.

Opportunities:

Nanotechnology is a multidisciplinary sector that incorporated the usage of nano-sized particles and devices for various applications such as diagnostics, targeted drug delivery, and the production of new therapeutic materials. Nanoparticles such as gold and silver have been utilized in biomedical and diagnostic applications, for the detection of viral particles for certain instances. Nanotechnology has proven to aid in treating viral infection by modes of various mechanisms. Moreover, the employment of nanotechnology in the development of new medicines has been acknowledged as a key enabling technology, capable of offering new and innovative medical solutions to address unmet medical needs. Thus, providing tools required for nanotechnological processes is an essential opportunity for the market players.

In the case of Covid-19, it took two weeks for public health officials to report the virus to the World Health Organization (WHO), and for scientists to isolate the virus and decipher the full genetic sequence. The discovery of this genetic code may elucidate the origins and the transmission of the disease, and also point to potential pharmaceutical targets for drug development. Time is of the essence on the frontline of this viral outbreak, therefore advancements in gene-editing technologies, particularly in CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-Cas9 (CRISPR-associated protein 9) may need to be harnessed in chronological order to accelerate the ongoing efforts to develop drugs and diagnostics. The significant effects of gene editing and the utilization of CRISPR-Cas9, Zinc Finger Nucleases, and other techniques for this method are a hotspot for market players.

Market Segmentation

Segmentation Analysis of Biotechnology Instruments Market:

Depending on Products, the life science consumables segment is anticipated to lead the Biotechnology Instruments Market during the period of forecast. The life science consumable is a vast field that includes research in food, forensic, cancer, and proteomics fields. Additionally, it also includes, nanobiotechnology, drug discovery, toxicology, veterinary, immunobiology, animal and plant tissue cultures. The rapid development in biotechnology instruments has boosted the growth of this segment. Moreover, various novel techniques have been discovered that can cure cancer and other life-threatening diseases which were previously declared to be fatal thus, supporting the growth of the life science consumables segment in the forecast period.

Depending on the Technology, the spectroscopy segment is expected to dominate the Biotechnology Instruments Market. Mass spectrometry is a type of spectroscopy, having wide application in diverse fields such as forensic toxicology, metabolomics, proteomics, pharma, biopharma, and clinical research. Moreover, drug testing and discovery, food contamination detection, pesticide residue analysis, isotope ratio determination, protein identification, and carbon dating are some specific applications of mass spectrometry thus driving the growth of this segment in the forecast period. The PCR segment is forecasted to grow at a significant growth rate attributed to the increasing applications of PCR in the forensic and life science field. The need for accurate diagnostics of certain viral diseases in a short period such as influenza and SARS CoV-2 is propelling the growth of the PCR segment.

Depending on Applications, the Biotechnology Instruments Market is segmented into clinical and research. The research segment is expected to have the highest share of the Biotechnology Instruments Market. The main driving factor of this segment is the rise in the worldwide fundings done by numerous governments to discover novel technologies to increase the yield of agricultural products, to develop novel efficient therapies to treat diseases, and to manufacture vaccines to control outbreaks of various diseases. Biotechnology instruments provide a safe and reliable atmosphere for research work thus, promoting the growth of this segment.

Depending on End-Users, the Pharma-Biotech segment is predicted to have the highest share of the Biotechnology Instruments Market throughout the forecast. Pharmaceutical companies are widely known for producing pharmaceutical drugs. These drugs are utilized to diagnose, cure, treat, and prevent diseases. According to Statista, the pharmaceutical industry is one of the largest sectors, with the global pharmaceutical market estimated nearly at 1.3 trillion U.S. dollars in 2020. Moreover, pharma companies are involved not only in the pure pharmaceutical business, but also produce medical technology and vaccines, and consumer health products with the usage of biotechnology instruments. Furthermore, there are both authenticate biotechnology companies as well as pharmaceutical companies which among other commodities also manufacture biotech products within their biotechnological divisions. Top leading global pharmaceutical companies have their biopharmaceutical divisions. Roche, a biotech-pharma company from Switzerland has the highest revenues from biotechnology products worldwide even though it is not a completely biotech company. Biotech companies use biotechnology instruments to generate their products, which are mostly medical drugs and genetically engineered crops.

Regional Analysis of Biotechnology Instruments Market:

The North American region is anticipated to lead the growth of the Biotechnology Instruments Market in the forecast period. The presence of major companies and highly skilled professionals are the major factors driving the Biotechnology Instruments Market growth in this region. Moreover, countries such as the US, and Canada have made huge amounts of funding for the technological advancements in biotechnology instruments to improve the diagnostics process and to enhance the research-oriented work for the findings of novel techniques to treat cancer and other deadly diseases. Furthermore, many companies in this region have collaborated to solve socio-economic and environmental challenges thus, encouraging the growth of Biotechnology Instruments in the North American region.

Asia-Pacific region is expected to grow at the highest growth rate in the forecast period. The collaborations with the multinational companies and the investments made by them for the establishment of manufacturing utilities is the main driving factor in this region. Moreover, the growing inclination of countries such as China, India, Japan, and Australia towards the advantageous effects of the utilization of biotechnology instruments in industrial, agriculture, energy, and environmental processes is promoting the expansion of the biotechnology instruments market. According to India Brand Equity Foundation (IBEF), the Indian biotechnology sector estimated US$ 63 billion in 2019 and is expected to reach US$ 150 billion by 2025, with a CAGR of 16.4%. Moreover, the contribution of the Indian biotechnology industry in the global biotechnology market is expected to grow to 19% by 2025 from 3% in 2017, thus supporting the development of the Biotechnology Instruments Market in the period of forecast.

The European region is forecasted to grow at a significant growth rate during the forecast period. The growing adoption of biotechnology-derived techniques for the production of medicines genetically modifies crops, and advanced laser technologies to treat cancer, Parkinson's, and other neurological disorders are the vital factors strengthening the expansion of the Biotechnology Instruments Market in the forecast period. Moreover, the increasing fundings for the development of the biotechnology sector by various governments and the presence of world-renowned health institutions are fueling the Biotechnology Instruments Market growth in this region.

Players Covered in Biotechnology Instruments market are :

• Abbott
• Agilent Technologies
• Alcon Inc.
• AngioDynamics
• Becton
• Dickinson and Company
• BioMerieux SA
• Bio-Rad Laboratories
• BioTek Instruments Inc.
• Candela Medical
• Cynosure LLC
• Danaher Corporation
• Endress+Hauser (Analytik Jena GmbH)
• F. Hoffmann-La Roche Ltd.
• IIlumina Inc.
• IRIDEX
• Lumenis
• Merck KGaA
• Novanta Inc.
• Perkin Elmer Inc.
• QIAGEN
• Siemens Healthineers
• Tecan Group AG
• Thermo Fisher Scientific Inc.
• Waters Corporation
• Zimmer MedizinSysteme and other Major Players.

Key Industry Developments In Biotechnology Instruments Market

• In August 2021, BD (Becton, Dickinson, and Company), a leading global medical technology company, declared the inauguration of a new, completely automated high-throughput diagnostic system utilizing sample management software algorithms and robotics to establish a new standard in automation for infectious disease molecular testing in the United States for core laboratories and other centralized laboratories.
• In July 2021, Agilent Technologies Inc. declared the launch of an optimized and verified method for PFAS Analysis in Water by triple quadrupole for liquid chromatography (LC/TQ) for testing per and poly-fluoroalkyl substances (PFAS) in surface and drinking water by employing mass spectrometry and liquid chromatography. With the usage of Agilent's PFAS drinking and surface water solution, customers can run real samples within hours, eradicating the need for an extensive investigation, optimization, and method development that usually take weeks.
• In July 2021, Bio-Rad Laboratories, Inc., a leading company in life science research and clinical diagnostic products, collaborated with Seegene, Inc., a global leading company in multiplex molecular diagnostics, for the clinical growth and commercialization of infectious disease molecular diagnostic solutions. With this agreement, Seegene will supply diagnostic tests for usage on Bio-Rad's CFX96™ Dx Real-Time PCR System for U.S. markets.
• In June 2021, Hitachi High-Tech Corporation declared the launch of AFM100 and AFM100 Plus systems, entry-level and intermediate-level prototypes of Hitachi's compact and multi-purpose Atomic Force Microscopes (AFM). These tools are developed to provide ease of usage and superior reliability for high-throughput R&D or quality control applications.